Hepatitis A vaccine. A new convenient single-dose schedule with booster when long-term immunization is warranted

Vaccine. 1994 Nov;12(14):1327-9. doi: 10.1016/s0264-410x(94)80028-x.

Abstract

A total of 162 anti-HAV-negative healthy adults were immunized with a single high dose (1440 ELISA units = 1 ml) of inactivated hepatitis A vaccine and a booster was given at month 6. Antibodies were measured after modification of a commercial ELISA kit, enabling quantification of titres down to 6 mIU ml-1. After 14 days, 96% of vaccinees had positive anti-HAV titres (> 20 mIU ml-1), and after 30 days all vaccinees had seroconverted. The geometric mean titres were 150 mIU ml-1 and 380 mIU ml-1 respectively. The booster dose at month 6 elicited a dramatic (25-fold) increase in antibody titres from 125 to 3090 mIU ml-1. Thus a single dose may be a convenient alternative to immunoglobulin for inducing rapid seroprotection, with a booster dose at month 6 ensuring long-lasting protection.

MeSH terms

  • Adolescent
  • Adult
  • Hepatitis A Vaccines
  • Hepatitis A Virus, Human / immunology*
  • Hepatitis Antibodies / biosynthesis
  • Humans
  • Immunization Schedule
  • Immunization, Secondary
  • Viral Hepatitis Vaccines / administration & dosage*
  • Viral Hepatitis Vaccines / adverse effects
  • Viral Hepatitis Vaccines / immunology

Substances

  • Hepatitis A Vaccines
  • Hepatitis Antibodies
  • Viral Hepatitis Vaccines